British Heart Foundation funding trial of experimental drug designed to prevent blood clots in coronavirus patients
June 16, 2020Manufacturing and Production COVID-19, blood clots, coronavirus
The British Heart Foundation is funding a trial for a drug that could prevent life-threatening blood clots that have been …
New Zealand no longer virus free after two new cases come from Britain
June 16, 2020Manufacturing and Production COVID-19, New Zealand, coronavirus, pandemic
New Zealand has reported its first new case of coronavirus after two COVID-19 positive women arrived in the country from …
Sinovac’s COVID-19 vaccine successfully generates immune response at Phase 1/2
June 16, 2020Manufacturing and Production, Research and Development COVID-19, Sinovac, Vaccine, coronavirus, pharma
As more than 130 efforts to develop an effective vaccine against the novel coronavirus continue to roll on, Beijing-based firm …
FDA revokes emergency approval of hydroxychloroquine and chloroquine
June 16, 2020Manufacturing and Production COVID-19, chloroquine, coronavirus, hydroxychloroquine
The FDA has revoked its emergency approval of hydroxychloroquine and chloroquine due to health risks and a lack of effectiveness …
Mundipharma names Marc Princen as Global Chief Executive Officer
June 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mundipharma, appointment
Marc Princen was revealed in mid-June as the new Global Chief Executive Officer (CEO) of the Mundipharma network, having taken …
COVID-19: UK and Europe life sciences regulatory developments
June 15, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Sidley Austin, coronavirus, pharma, regulation
Marie Manley, Partner, and Bethany Wise, Trainee Solicitor, at Sidley Austin look at UK and EU life sciences regulatory developments …
Tremfya’s skin clearance benefit lasts up to four years in plaque psoriasis patients, Janssen says
June 15, 2020Research and Development, Sales and Marketing Janssen, Tremfya, plaque psoriasis
Janssen has revealed new data on its interleukin (IL)-23 inhibitor Tremfya (guselkumab) at the American Academy of Dermatology (AAD) virtual …
Fear of a coronavirus second wave as China reports highest number of cases in months
June 15, 2020Sales and Marketing COVID, COVID-19, coronavirus, pandemic
China reported its highest amount of coronavirus cases in months as a new outbreak has been linked to a food …
AstraZeneca to supply Europe with 400 million COVID-19 vaccine doses
June 15, 2020Sales and Marketing COVID, COVID-19, Vaccine, coronavirus
Multiple European governments have been involved in a deal with AstraZeneca to access a supply of the British drugmakers’ potential …
NICE greenlights Roche’s Rozlytrek for ROS1+ advanced non-small cell lung cancer
June 15, 2020Sales and Marketing NICE, Roche, Rozlytrek, UK, lung cancer
Roche’s Rozlytrek (entrectinib) has secured recommendation for NHS use in England and Wales after NICE backed the drug in final …
AbbVie’s Venclexta plus azacitidine shows improved survival and remissions rates in leukaemia patients
June 15, 2020Sales and Marketing AbbVie, leukaemia
AbbVie have announced positive results from its latest Phase 3 clinical trial where Venclexta plus azacitidine improved survival and remission …
Takeda jettisons non-core portfolio in Asia Pacific to Celltrion for a potential $278 million
June 12, 2020Medical Communications, Sales and Marketing Takeda, celltrion, pharma, sale
Takeda continues its mission to reduce its debt in the wake of its $49 billion acquisition of Shire in January …
Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July
June 12, 2020Medical Communications COVID-19, coronavirus
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The …
Mylan and Biocon’s Semglee, biosimilar to Sanofi’s Lantus, approved by FDA for type 1 and 2 diabetes
June 12, 2020Medical Communications, Sales and Marketing FDA, Lantus, Mylan Biocon, Sanofi, Semglee, diabetes
Mylan and Biocon have scored FDA approval with their insulin glargine injection Semglee, a biosimilar to Sanofi’s Lantus, in both …
Top Ten most popular articles on Pharmafile.com this week
June 12, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing coronavirus, top 10
The news this week continues to be dominated by breakthroughs in COVID-19 treatments, with a US clinical trial of the …
Coronavirus has caused widespread disruption to cancer care in England
June 12, 2020Medical Communications COVID-19, coronavirus
Figures show that cancer care in England has faced major disruption due to a big drop in referrals from GPs …
Study finds that MDMA has long-term benefits for treating PTSD
June 11, 2020Business Services MDMA, PTSD
PTSD patients being treated with MDMA experience numerous beneficial effects that hold strong for well after a year after completing …
MSD’s Keytruda misses the mark at Phase 3 in advanced bladder cancer
June 11, 2020Research and Development MSD< Keytruda, bladder cancer, pharma, trial failure
MSD has announced the disappointing findings that its anti-PD-1 immunotherapy Keytruda (pembrolizumab), when used either alone or combined with chemotherapy, …
Eli Lilly’s coronavirus antibody treatments could be available by September
June 11, 2020Business Services COVID, COVID-19, coronavirus
An antibody therapy for coronavirus could be available from Eli Lilly as early as September, according to one of its …
AbbVie and Genmab sign drug development and commercialisation deal worth up to $4bn
June 11, 2020Research and Development AbbVie, Genmab, partnership, pharma
AbbVie has joined forces with Genmab to develop and commercialise three of the latter’s early-stage Genmab drug products – epcoritamab …
Latest content
Major funding opportunity opens for early cancer diagnostics
Androlabs receives UK authorisation for new Testavan presentation
CEPI backs African-led Bundibugyo Ebola vaccine development
Cytomos appoints life sciences executive to board
